Ambry Genetics

02/03/2026

Caitlin Reid, MS, LGC, explores the BMPR1A gene and its connection to juvenile polyposis syndrome (JPS). JPS causes the development of multiple "juvenile" polyps in the gastrointestinal tract, most commonly in the colon, but also in the stomach and small intestine. Dive deeper for clinical insights: https://hubs.ly/Q041nsh_0

02/02/2026

This National Cancer Prevention Week, take charge of your health with informed choices and early action. Ambry empowers you to understand your hereditary cancer risk through genetic testing.
Know your family history, talk to your doctor about regular screenings and genetic tests, and make healthy lifestyle choices. Share to spread awareness—prevention starts with knowledge.

02/02/2026

Ambry has been helping patients get access to testing with greater clarity by leveraging RNA since 2019. We are thrilled to announce that we have completed over 1,000,000 RNA analyses for patients!
Read the press release: https://hubs.ly/Q041jWjQ0

01/30/2026

Are you a recent Genetic Counseling grad? We've helped hundreds study with our Genetic Counseling Boards Review. Join us for this trivia-style event. We have one more session on February 3. Register today:
https://hubs.ly/Q040W8y_0

01/29/2026

join us for a webinar on Wednesday, February 4, at 10 am PST, with Jennifer Leib as she discusses policy efforts to increase access to .
https://hubs.ly/Q040TN8f0

01/29/2026

Ambry is dedicated to advancing equity in genetic testing. +RNAinsight®, paired DNA/RNA testing, generates novel functional evidence that helps close data gaps and leads to a preferential improvement in accuracy among non-White populations.
Learn more in our white paper: The Growing Impact of Concurrent DNA and RNA Sequencing. https://hubs.ly/Q040wrpV0

01/28/2026

Ambry is a proud sponsor of the Uplifting Athletes' Young Investigator Draft.
On January 31, we will celebrate the 2026 Young Investigator Draft Class at Lincoln Financial Field in Philadelphia, PA. These incredible researchers are making a difference for the rare disease community and will be awarded with research grant funding.
To learn more or for tickets, visit:
https://hubs.ly/Q040Nl5d0

01/28/2026

We're grateful for our many clinician partners. Check out their reflections on providing proactive, personalized care with The Ambry CARE Program®.

01/27/2026

This Gene Scene covers pathogenic variants in KCNH2, known to cause KCNH2-related long QT syndrome and KCNH2-related short QT syndrome
https://hubs.ly/Q040w6JH0

01/23/2026

Ambry is a proud member of the Genomic Answers for Children’s Health Alliance. We support the bipartisan Genomic Answers for Children’s Health Act, which was recently introduced in the House. This important legislation ensures pediatric Medicaid coverage for medically necessary genomic sequencing, helping sick children and their families get timely answers and care. Learn more by visiting https://hubs.ly/Q0404rk70.

In the U.S., an estimated 30 million Americans have a rare disease. More than half of those Americans are children.

01/22/2026

Over the years, Ambry Genetics has learned a lot about how RNA sequencing results can challenge our expectations in variant interpretation. We're proud to share our new paper in Genes, “A Plot Twist: When RNA Yields Unexpected Findings in Paired DNA–RNA Germline Genetic Testing,” which presents cases where paired DNA–RNA testing revealed unexpected splicing outcomes and reinforces the value of paired testing in clinical genomics. https://hubs.ly/Q03_wgGd0

01/21/2026

Have you visited the new Progeny website? Along with a refreshed Progeny logo, our website has been updated to better reflect what Progeny helps you do:
· enhance clinical care
· streamline workflows
· conduct powerful research
With new content, improved navigation, and reorganized resources, it’s now easier to find information that supports your practice every day.
https://hubs.ly/Q03_w5jr0